Valeo Financial Advisors, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Valeo Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$65.78 - $105.02 $6,578 - $10,502	-100 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$64.07 - $91.75 $12,493 - $17,891	-195 Reduced 66.1%	100 $7,000
Q4 2020 Feb 11, 2021	BUY	$65.07 - $98.24 $12,688 - $19,156	195 Added 195.0%	295 $25,000
Q3 2020 Oct 28, 2020	SELL	$59.04 - $77.95 $354 - $467	-6 Reduced 5.66%	100 $7,000
Q2 2020 Jul 20, 2020	BUY	$29.01 - $74.23 $174 - $445	6 Added 6.0%	106 $8,000
Q1 2020 Apr 13, 2020	BUY	$27.51 - $57.29 $2,751 - $5,729	100 New	100 $4,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.